Localized Renal Cell Carcinoma
Localized Renal Cell Carcinoma
Zachary BessetteASCO 2023 | May 30, 2023
Tumor grade, sarcomatoid features may influence outcomes with adjuvant nivo/ipi in patients with RCC after nephrectomy.
Read More
Emily MenendezLocalized Renal Cell Carcinoma | May 11, 2023
Partial nephrectomy has been gaining traction as an effective treatment for RCC due to its safety and efficacy.
Emily MenendezLocalized Renal Cell Carcinoma | April 14, 2023
Tumors with only a VHL mutation were associated with better outcomes compared with tumors containing additional mutations.
Akhil Abraham Saji, MDLocalized Renal Cell Carcinoma | March 30, 2023
AUA guidelines for localized RCC have thermal ablation as an alternative modality. EAU guidelines are conflicting.
Emily MenendezLocalized Renal Cell Carcinoma | March 23, 2023
SAbR could potentially serve as a new noninvasive alternative treatment, but data on the procedure are limited.
Emily MenendezLocalized Renal Cell Carcinoma | March 10, 2023
A review of adjuvant therapies shows patient characteristics that may result in favorable treatment responses.
Steven Campbell, MD, PhDASCO GU Symposium 2023 | February 18, 2023
Steven Campbell, MD, PhD, overviews the surgical options available for patients with localized renal cell carcinoma.
Zachary BessetteASCO GU Symposium 2023 | February 17, 2023
Researchers presented the largest retrospective characterization of localized RCC with sarcomatoid dedifferentiation.
Matthew Zibelman, MDASCO GU Symposium 2023 | February 16, 2023
Matthew Zibelman, MD, highlights SOC adjuvant therapy for localized RCC and practice-changing potential of novel therapies.
Zachary BessetteLocalized Renal Cell Carcinoma | January 20, 2023
A new study evaluated renal function outcomes for patients with oncocytoma managed with surveillance vs nephrectomy.
Zachary BessetteLocalized Renal Cell Carcinoma | December 20, 2022
Guadecitabine may be well tolerated in patients with dSDH tumors, including HLRCC-RCC, according to results of a new study.
Leah LawrenceLocalized Renal Cell Carcinoma | December 7, 2022
Cryoablation and heat-based thermal ablation represent alternative management options for frail and/or comorbid RCC patients.
Akhil Abraham Saji, MDJournal | November 22, 2022
Stereotactic body radiotherapy can benefit RCC patients deemed unfit for surgical therapy.
Leah LawrenceLocalized Renal Cell Carcinoma | October 18, 2022
Checkmate 914 assigned patients to nivolumab plus ipilimumab or placebo and found no difference in disease-free survival.
GU Oncology Now EditorsSUO Annual Meeting 2021 | December 2, 2021
Researchers evaluated the new AUA risk stratification system for survival in patients with clear cell or papillary RCC.
GU Oncology Now EditorsAUA 2021 | September 13, 2021
There is little to no clinical value in surveillance of pulmonary recurrence following resection of T1a renal cell carcinoma.